Law360, New York (September 23, 2010, 4:15 PM EDT) -- On Friday, Sept. 17, 2010, the U.S. Department of Health and Human Services (HHS) released notice of its intention to consider a parallel regulatory and reimbursement review process that could result in simultaneous marketing clearance from the U.S. Food and Drug Administration and Medicare national coverage for new medical products.
Public comments are due by Dec. 16, 2010. The notice also announces the intent to create a pilot program for parallel review of medical devices once the agencies have reviewed comments submitted.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.